Acute Myeloid Leukemia: ASCO Tumor Boards

This is free case-based activity that includes discussion of a forty-four year old man presents with fatigue that has been worsening over 3 weeks.  A complete blood count shows a hematocrit of 25%, a white blood cell count of 17,000/mm3 with frequent blasts, and a platelet count of 46,000/mm3. A bone marrow examination shows 40% myeloblasts. Fluorescence in situ hybridization shows monosomy 7 and 5q- in the majority of blasts. 

Learning Objectives

  • Identify those diagnostic tests that are necessary for allocating younger patients with AML to the most appropriate therapies
  • Discuss the possible induction therapies available as initial therapy for patients with AML
  • Define the categories of patients with AML for whom hematopoietic cell transplantation is an appropriate therapeutic option
Continuing Education Credit
1 Credit/Point is available for participation in this course. Certificate and credit types available include:
  • AMA PRA Category 1 Credits™ 
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on November 18, 2018. Participants must complete all necessary course components by this date to receive credit.